Sodium-Glucose Co-transporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Bariatric Surgery: A Case and Literature Review

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce cardiovascular, kidney, and overall mortality. SGLT2i are also associated with a rare adverse event, euglycemic diabetic ketoacidosis (EDKA). This report describes a case of EDKA one day after bariatric surgery in a 51-year-old female with ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapila, Vaishali, Topf, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432437/
https://www.ncbi.nlm.nih.gov/pubmed/34527480
http://dx.doi.org/10.7759/cureus.17093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432437/
https://www.ncbi.nlm.nih.gov/pubmed/34527480
http://dx.doi.org/10.7759/cureus.17093

Ejemplares similares